The prevention of glucocorticoid-induced osteoporosis in patients with immune thrombocytopenia receiving steroids: a British Society for Haematology Good Practice Paper

Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study

(2018) Kenneth G Saag et al.   Lancet Diabetes & Endocrinology

Effectiveness of Oral Bisphosphonates in Reducing Fracture Risk Among Oral Glucocorticoid Users: Three Matched Cohort Analyses

(2017) M Amine Amiche et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Use of systemic glucocorticoids and the risk of major osteoporotic fractures in patients with sarcoidosis

(2017) O. A. Oshagbemi et al.   OSTEOPOROSIS INTERNATIONAL

2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis

(2017) Lenore Buckley et al.   ARTHRITIS CARE & RESEARCH

UK clinical guideline for the prevention and treatment of osteoporosis

(2017) J. Compston et al.   Archives of Osteoporosis

How I treat refractory immune thrombocytopenia

(2016) A. Cuker et al.   BLOOD

High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial

(2015) Y. Wei et al.   BLOOD

Fracture rate associated with quality metric-based anti-osteoporosis treatment in glucocorticoid-induced osteoporosis

(2015) R. A. Overman et al.   OSTEOPOROSIS INTERNATIONAL

Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials

(2015) M. A. Amiche et al.   OSTEOPOROSIS INTERNATIONAL

Influence of recency and duration of glucocorticoid use on bone mineral density and risk of fractures: population-based cohort study

(2013) S. R. Majumdar et al.   OSTEOPOROSIS INTERNATIONAL

Management of Glucocorticoid-Induced Osteoporosis

(2012) R. Rizzoli et al.   CALCIFIED TISSUE INTERNATIONAL

Oral bisphosphonates reduce the risk of clinical fractures in glucocorticoid-induced osteoporosis in clinical practice

(2012) T. Thomas et al.   OSTEOPOROSIS INTERNATIONAL

A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis

(2012) S. Lekamwasam et al.   OSTEOPOROSIS INTERNATIONAL

Bone mass and biochemical markers of bone turnover in children and adolescents with chronic immune thrombocytopenia: Relation to corticosteroid therapy and vitamin D receptor gene polymorphisms

(2012) Azza A. G. Tantawy et al.   PLATELETS

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia

(2011) C. Neunert et al.   BLOOD

Reduced corticosteroid use in adult patients with primary immune thrombocytopenia receiving romiplostim

(2011) Marc Michel et al.   Hematology

Incidence of symptomatic vertebral fractures in women of childbearing age newly treated with high-dose glucocorticoid

(2010) Takao Sugiyama et al.   Gender Medicine

Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Thirty-six-month results of a randomized, double-blind, controlled trial

(2009) Kenneth G. Saag et al.   ARTHRITIS AND RHEUMATISM

International consensus report on the investigation and management of primary immune thrombocytopenia

(2009) D. Provan et al.   BLOOD

Effects of Bisphosphonate Administration on the Bone Mass in Immune Thrombocytopenic Purpura Patients Under Treatment With Steroids

(2009) Shosaku Nomura et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

Clinical Characteristics and Medication Use among Premenopausal Women with Osteoporosis and Low BMD: The Experience of an Osteoporosis Referral Center

(2009) Adi Cohen et al.   JOURNAL OF WOMENS HEALTH

Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial

(2009) David M Reid et al.   LANCET

Late Side Effects of High-dose Steroid Therapy on Skeletal System in Children With Idiopathic Thrombocytopenic Purpura

(2008) Zühal Keskin Yldrm et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY